Patient Outcomes in Resected Combined Hepatocellular Cholangiocarcinoma (cHCC-ICC) and Intrahepatic Cholangiocarcinoma: A Single Center Study
cHCC-ICC is a rare entity that needs to be further studied to improve patient outcomes. Further studies are warranted and may suggest the need for more aggressive initial treatment strategies in patients diagnosed with cHCC-ICC.
Authors
- Ali Zarrinpar (ORCID: https://orcid.org/0000-0002-6812-1816)
- Thomas J. George (ORCID: https://orcid.org/0000-0002-6249-9180)
- Rick Y. Lin (ORCID: https://orcid.org/0000-0001-6226-0375)
- Steven J. Hughes (ORCID: https://orcid.org/0000-0002-5688-6942)
- Ibrahim Nassour (ORCID: https://orcid.org/0000-0002-9845-1074)
- İlyas Şahin (ORCID: https://orcid.org/0000-0003-2070-9319)
- Muhammet Özer (ORCID: https://orcid.org/0000-0002-9579-1372)
- Doga Kahramangil (ORCID: https://orcid.org/0000-0001-7292-7997)
Institutions
- Harvard University (US)
- University of Florida (US)
- Massachusetts General Hospital (US)
- Dana-Farber Cancer Institute (US)
Publication Details
- Journal
- Cancers
- Published
- 2024-11-20
- DOI
- https://doi.org/10.3390/cancers16223878
- Primary Topic
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00